Let's Get Started

News

NMRD Stock: Why is Nemaura Medical (NASDAQ: NMRD) A Top Stock To Watch in February?

NMRD Stock: Why is Nemaura Medical (NASDAQ: NMRD) A Top Stock To Watch in February?

Jan 26, 2023

Over the past week, the Nemaura Medical Inc (NASDAQ: NMRD) stock has been in the middle of a solid rally and recorded gains of 56% to emerging as one of the stock to watch. As it happens, the NMRD stock hit its highest level since mid-October last year.

Nemaura Medical Inc

Company Name: Nemaura Medical Inc

Ticker: NMRD

Exchange: NASDAQ

Website: https://nemauramedical.com

Nemaura Medical Inc Summary:

Nemaura Medical Inc. is a medical technology company developing and commercialising non-invasive wearable diagnostic devices. The Company is currently also commercialising sugarBEAT® and proBEAT™. sugarBEAT®, a CE mark approved Class IIb medical device, as a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and prediabetes to better manage, reverse, and prevent the onset of diabetes.

There are certain specific triggers that led to the remarkable rally in the NMRD stock.

#1 Medical’s Program Shows Weight Loss In 100% Of Participants

One of those came about earlier in the week on January 24 when the company announced the initial results from the patient studies that had been conducted with the National Health Service (NHS) of the United Kingdom for Miboko, its metabolic health program.

The results were positive as the patients recorded an average weight loss of 3.7 pounds and all the patients experienced some degree of weight improvement.

This news had a major positive impact on NMRD stock and is one of the top stock to watch.

#2 Commences Pilot Program of Miboko with the NHS

While that was quite clearly a significant development it should be noted that the announcement with regards to the study for Miboko in collaboration with the NHS had been announced back on November 29, 2022.

Mikobo is the first product in its category to have a non-invasive glucose sensor in a lifestyle app. It not includes information with regard to drinking and good intake but also provides analytics and educational content. At the end of the analysis, the app provides the user with a metabolic score based on diet and other important factors.

#3 Solid Industry Growth

Nemaura is entering the Continuous Glucose Monitoring Market with the product and it is a market that is expanding rapidly. The market was worth as much as $6.13 billion back in 2021 and by 2030 it is expected to command a valuation of $16.33 billion, which reflects a CAGR of 17.33%.

So, considering the latest news and big jump, NMRD stock is one of the other top stock to watch for the month of February.

read more
A2Z Smart Technologies (NASDAQ:AZ) Is The Stock to Watch Following Multiple News

A2Z Smart Technologies (NASDAQ:AZ) Is The Stock to Watch Following Multiple News

Jan 25, 2023

At this point in time, investors are hotly on the trail of A2Z Smart Technologies Corp (NASDAQ:AZ) and that becomes apparent when one looks into the price action in the stock and is the notable stock to watch. Over the course of the past week alone, AZ stock has clocked gains of 43% and that took the gains over the past month to as much as 92%.

Why Such a Big Jump?

AZ stock has been witnessing continuous buying after announcing multiple news. Firstly, the stock reached a key partnership with Lenovo Group Limited. Secondly, the company announced a launch of a new Smart Cart model.

A2Z Smart Technologies Corp

Company Name: A2Z Smart Technologies Corp

Ticker: AZ

Exchange: NASDAQ

Website: https://a2zas.com/

A2Z Smart Technologies Corp Summary:

A2Z Smart Technologies Corp. creates innovative solutions for complex challenges. A2Z’s flagship product is an advanced proven-in-use mobile self-checkout shopping cart.

With its user-friendly smart algorithm, touch screen, and computer-vision system, Cust2Mate streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply “pick & go”, and bypass long cashier checkout lines. This results in a more efficient shopping experience for customers, less unused shelf-space and manpower requirements, and advanced command and control capabilities for store managers.

As AZ stock has soared over the past month, let’s analyze the key catalysts:-

#1 Big Partnership With Lenovo Group

Last Friday, the company announced that its subsidiary has partnered with Lenovo Group Limited. As per the joint venture, A2Z Smart Technologies will use Lenovo solutions in its revolutionary Cust2mate Smart Cart solution and Lenovo will actively sell and promote the solution through its extensive worldwide channels.

Hila Kraus, Head of Sales stated, “The Cust2Mate platform with embedded Lenovo OEM solution is designed to serve shoppers from the moment they enter the store until they leave-without any friction, lines, or delays.”

#2 Launches Next Generation V2.8 Light Smart Cart

AZ stock hit its 4-month high recently as a key contender for the stock to watch this year. One of the major catalysts behind the latest rally in the stock came about earlier this week when the company announced that it had launched its latest Smart Card model. The product in question is expected to further enhance the current range of offerings from A2Z Smart.

The company announced that the latest version of the model had been created after consulting with some of the major retail companies in the world from the Asian and European markets.

#3 It Will Display Its Smart Cart Line of Products at the NRF 2023 Big Retail Show In NYC

Moreover, earlier on in the month on January 12, the company made another announcement that had come as a positive trigger for the A2Z Smart stock. It announced that it was going to be one of the participants in the NRF Big Retail Show. The company announced at the time that it was going to display its Smart Cart Line at the event.

Considering the recent multiple news, AZ stock should be on your radar as a stock to watch in 2023.

read more
Will AgriFORCE Growing Systems Ltd (NASDAQ:AGRI) Patent News Trigger Further Rally?

Will AgriFORCE Growing Systems Ltd (NASDAQ:AGRI) Patent News Trigger Further Rally?

Jan 18, 2023

AgriFORCE Growing Systems Ltd (NASDAQ:AGRI) stock is flying with a price-volume breakout!!

It was hardly a surprise that the AgriFORCE Growing Systems Ltd (NASDAQ:AGRI) stock went on a major really yesterday and ended up hitting a four-month high following a jump of 29% and closed at a 4-month high. Considering the magnitude of the gains, investors are expected to be in hot pursuit over the course of the coming days.

Why Such a Big Rally?

The news that triggered the rally in the stock was the award of the patent for its proprietary method for the natural processing and modification of gains by the United States Patent and Trademark Office.

AgriFORCE Growing Systems Company Summary

Company Name: AgriFORCE Growing Systems Ltd.

Ticker: AGRI

Exchange: NASDAQ

Website: https://agriforcegs.com/

AgriFORCE Growing Systems Company Summary:

AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI; AGRIW) is an agtech company focused on building an integrated agtech platform that combines the best technology, intellectual property, and knowledge to solve an urgent problem – providing the best solutions to help drive sustainable crops and nutritious food for people around the world.

The AgriFORCE vision is to be a global leader in delivering plant-based foods and products through an advanced and sustainable agtech platform that makes a positive change in the world—from seed to table. Additional information about AgriFORCE is available at: www.agriforcegs.com.

#1 – AgriFORCE Granted Patent Related to its Proprietary Methods for Processing Nutritious Foods Under the UN(THINK)™ Foods Brand

The company is highly innovative and is engaged in the advancement of agricultural technology which could promote sustainable agriculture as well as crop processing operations.

By way of this particular process, it would be possible to turn grains of rice, pulses, and other seeds into fiber-rich, high-protein, and low-starch baking flour products. It is clear to see that it is a patent that could lead to a revolution in the fast-growing nutritious foods space.

It ought to be noted that the unique process had been acquired by AgriFORCE through the acquisition of Manna International Group back in May last year. The acquisition was part of the company’s overall aggressive acquisition strategy and it seems it may have paid off handsomely following the award of the patent.

#2 – AGRI stock Trades Above 20-Day and 50-Day EMA

Tuesday’s big rally has pushed the stock above key moving averages – signaling a short-term momentum trade. The stock is now trading well above the 20-Day and 50-Day EMA of $1.20 and $1.15 respectively.

Moreover, the stock closed at a 4-month high triggering a multi-month price-volume breakout.

#3- Growth Through Acquisition – Delphy Group’s Acquisition In Focus

Last month on December 28 the company announced that it had got shareholder approval for the acquisition of Delphy Group, which is expected to help AgriFORCE in offering its products in the global market easily.

The acquisition is expected to be closed at some point in the coming weeks. The company has also stated that throughout the course of 2023, it expects to witness certain developments which could further accelerate its growth. AgriFORCE remains committed to its aggressive merger and acquisition strategy.

The company said that ” We will continue to drive our M&A strategy to further strengthen our AgTech 2.0 platform.”

#4 Impressive Outlook

The company is projected to bring the first products under UN(THINK) Foods to market. In particular, with the B2B and direct-to-consumer launch of Awakened Flour, and hope to create a new standard for sprouted flours.

Following this, the company plan to launch our Power Flour which will bring superior nutrition with no compromise to consumers. Additionally, they have several other consumer products in the pipeline, for which we intend to provide additional details in 2023.

Moreover, AgriFORCE will start advancing the expansion of Delphy into North America as well as continue to build our Delphy Digital platform and suite of services.

The company noted ” As we look ahead, we believe we have secured the foundational pieces to transform our business in the near term. We believe 2023 will be a pivotal year in the company’s history and that we have laid the foundation in 2022 to achieve major achievements and successes in the coming year.”

read more
Sharps Technology, Inc. (NASDAQ: STSS) Has An Accelerated Near-Term Path Product For The Commercialization & Accelerated Revenue Growth!

Sharps Technology, Inc. (NASDAQ: STSS) Has An Accelerated Near-Term Path Product For The Commercialization & Accelerated Revenue Growth!

Jan 11, 2023

With An Accelerated Near-Term Path For Product Commercialization And Expanded Manufacturing Capacity, Sharps Technology, Inc. (NASDAQ: STSS) Will Have The Ability To Support The Industry With Innovative, Market Leading Injectable Drug Delivery Solutions And Accelerate A Path Towards Revenue Growth.

STSS
Sharps Technology, Inc. (NASDAQ: STSS)

Newly NASDAQ-traded Sharps Technology, Inc. (NASDAQ: STSS) offers innovative injectable syringe solutions to a global healthcare crisis that is not being talked about nearly enough.

  • Most syringes waste a significant amount of injectable medicine which is thrown away with the used needle/syringe.

  • This adds cost and reduces the availability of life-saving injectable drugs for us all. Whether we are looking at a pandemic response, hard-to-manufacture drug products, or managing long-term chronic illness, we can’t afford to waste this precious supply.

  • The problem is sufficiently worrisome that the Federal Government is passing new legislation (January 1, 2023) requiring pharmaceutical companies to pay financial penalties for injectable drugs which are thrown away with the syringe and not injected into the patient.

Sharps Technology Company Summary

Company Name: Sharps Technology, Inc.

Ticker: STSS

Exchange: NASDAQ

Website: www.sharpstechnology.com

Sharps Technology Company Summary:

Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems.

The company’s product lines focus on low waste and ultra-low waste syringe technologies that incorporate both passive and active safety features.

These features protect front line healthcare workers from life-threatening needle stick injuries and protect the public from needle re-use.

Sharps Technology has extensive expertise in specialized prefilled syringe systems and ready to use processing.

The company has a manufacturing facility in Hungary and has partnered with Nephron Pharmaceuticals to expand its manufacturing capacity in the US.

Sharps Technology STSS

Sharps Technology has agreed to manufactured in collaboration with Nephron Pharmaceuticals at the Inject EZ facility in West Columbia, South Carolina.

Jan. 10, 2023

Announces the advancement of the Company’s specialized prefillable syringe (“PFS”) system product line, which will be manufactured in collaboration with Nephron Pharmaceuticals at the Inject EZ facility in West Columbia, South Carolina.

Braden Miller, Sharps Director of Product Management, commented, “Sharps has developed an alternative high-quality solution to glass syringes through the use of inert polymers such as Cyclic Olefin Polymer (COP) and Cyclic Olefin Copolymer (COC), which offers a high-quality solution compared to traditional glass syringe systems.

These polymer syringes have many of the same characteristics as current pharmaceutical glass designs to support long term drug stability and increase shelf life for customers in the pharmaceutical segment. Polymer syringes can also be made into custom configurations, which can eliminate breakage, minimize dead space, reduce contamination, and support the development of custom devices including autoinjectors.

The ability to produce these innovative products using advanced manufacturing techniques creates additional advantages in the areas of quality, performance and safety when compared to similar glass syringe products. We look forward to introducing this line of next generation products to the market.”

Sharps Technology commenced manufacturing of their much-needed ultra-low waste smart safety syringe products in their European operation in Hungary.

Dec. 20, 2022

Announced they have commenced manufacturing of their much-needed ultra-low waste smart safety syringe products in their European operation in Hungary.

The plant has been producing products and will begin shipments to support the distribution and sales agreement with Nephron Pharmaceuticals by the end of the year, and customer agreements in Europe in early 2023. The production of these specialty syringe products will ramp up over the next several months to increase supply.

Sharps innovative syringe designs provide a beneficial set of features and advantages for the healthcare industry.

These syringe product features include a combination of ultra-low waste, passive and active safety, and reuse prevention.

By combining all these features and building them into a portfolio of syringe offerings, it will create product platforms that can help drive down the cost of healthcare treatments.

Sharps Technology signed of a distribution agreement with partner Nephron Pharmaceuticals

Dec. 13, 2022

Announced the signing of a distribution agreement with partner Nephron Pharmaceuticals. This is a strategic first step in building the larger partnership between the two companies and is in support of their recently announced collaboration.

“This distribution agreement opens so many possibilities for Sharps Technology and Nephron Pharmaceuticals,” commented Robert Hayes, Sharps Technology CEO. “The timing is perfect in that we are expanding our ability to supply innovative drug delivery systems at a point when the market is in demand for them. Through this distribution plan, Sharps Technology will be able to deliver increased capacity, driving growth for one of the high value product segments of our business.”

  • Each year almost  20 billion injections are administered, globally and the World Health Organization (WHO) are advocating for the use of low waste syringes, with passive safety devices which engage automatically and have auto disable features.

  • STSS anticipates signing its first product orders any moment now this development will represent a huge milestone for this recently debuted NASDAQ company, and should provide them with a solid foundation for growth.

  • The company has raised $16M to scale operations in the coming quarters as they begin to meet the strong and growing demand for smart safety syringes

The global vaccines market is projected to grow from $61.04 billion in 2021 to $125.49 billion in 2028 at a CAGR of 10.8% in the forecast period, 2021-2028.

Vaccines are the most powerful and cost-effective way to protect billions of people in the world, and according to the WHO, immunization awareness and government initiatives have helped prevent 2-3 million deaths a year.

The Covid-19 outbreak led to a shutdown of syringe manufacturing which in turn led to a supply shortage at a global scale.

Mergers and acquisitions of companies such as STSS are highly attractive and are providing the needed innovation to the vaccine market.

The rise in the need for vaccinations and immunizations, plus a surge in the geriatric population, an increase in the number of surgical procedures, as well as a rise in chronic diseases have contributed to a demand for syringes.

Specialty Syringes – Vial Application 

  • Global Smart Syringe Market @ $14 billion USD by 2026 w10.0%+ CAGR 

  • Types: Auto-Disable Syringes and Safety Syringes

  • Applications: Vaccination and Drug Delivery

  • End Users: Hospitals, HMOs and Clinics

  • Target Markets: North America, Europe, and ROW

  • Sharps Technology listed as a supplier

The Pre-Filled Syringe (PFS)/Ready- To- Fill (RTF) syringe product segment will be a priority for the company through its collaboration with Nephron, and is expected to be a gamechanger for the company.

PRE-FILLED SYRINGES MARKET

  • Pre-filled syringes have emerged as one of the fastest-growing choices for unit-dose medication as the pharmaceutical industry seeks new and more convenient drug delivery methods.

  • With PFS/RTF syringes, pharmaceutical companies are able to minimize drug waste and increase product life span, while patients are able to self-administer injectable drugs at their home instead of the hospital.

Ready-To-Use – Pre-Filled Syringes:

  • Types: Plastic and Type I B/S Glass 

  • Applications: Vaccines, Diabetes, Complex High Value Therapies (Gene-Therapy)

  • End Users: Branded Pharma, CMOs, and Biologics

  • Target Markets: North America

There is a growing demand for efficient and easy-to-use drug delivery devices and increasing efforts of healthcare professionals to reduce hospital errors are the principal factors driving the market growth.

STSS announced over the summer that it had completed its acquisition of Safegard Medical’s syringe manufacturing facility in Hungary.

The manufacturing facility is located 2 hours from Budapest (160km from Budapest Airport)

  • 40,000 sq. ft. factory on 250,000 sq. ft. site

  • 20-year history of safety syringe manufacturing

  • FDA registered since 1999

  • ISO 13485 certified

  • CE Mark approved products

  • Injection molding and assembly expertise

  • ETO on-site sterilization capacity

“The acquisition of our first manufacturing facility is an important milestone in our transformation from an R&D-focused enterprise to revenue-generating commercial operations. With the acquisition now complete, with the addition of further assembly and manufacturing capacity, our team is confident we can deliver world-class products to meet the strong and growing demand for smart safety syringes, a market forecasted to reach $14 billion globally by 2026.”

Robert Hayes, CEO of Sharps Technology

IN SUMMARY

Sharps Technology, Inc. (NASDAQ: STSS) is the newest player in the drug delivery device market to go public and could see tremendous blue-sky growth in its future as it continues to ramp up its commercialization efforts.

  • The Company recently announced a significant partnership with Nephron Pharmaceuticals with an anticipated launch into the market in early 2023.

  • STSS anticipates shipping first orders of vial draw product by the beginning of 2023 and ready to fill product in mid-2023 to create initial revenue in 2023 and profits in early 2024.

  • With the global shortage of syringes that comply with the World Health Organization (WHO) requirements, there is a strategic opportunity for STSS to take market share and support the healthcare industry with a better drug delivery platform.

  • The combination of features and benefits for the Sharps products will save lives and eliminate the waste of critically needed medical treatments and therapies for the industry!

  • There’s a key opportunity for STSS to grab a big piece of the market with its proprietary smart safety syringe technology designed to eliminate two million potentially infectious accidental needlestick injuries, as well as billions of dollars in medicine wasted with today’s inefficient syringes with their low-dead space feature.

To reiterate, the company anticipates signing its first distributor agreement during the fourth quarter of 2022, which could be at any moment!

FULL DISCLAIMER

read more

BCAN Stock Price Could Be Explosive: Signs First Cannabis Commercial Agreement

Nov 2, 2022

BYND Cannasoft Enterprises Inc. BCAN Stock Price could go to the moon.

It is an integrated software cannabis company, based in Israel with a disruptive platform for the $52 BILLION US Cannabis Industry

Lets Take a closer look at 2 talking points for this blossoming Cannabis Giant.

# 1 Talking Point

BYND Cannasoft Enterprises Inc. owns and markets a proprietary customer relationship management  known as “Benefit CRM.”

For those of you reading that are not familiar with CRM, it is designed specifically to manage customers via SAAS platform.

BYND’s Benefit CRM software enables businesses to optimize their activities.

Imagine a software that manages sales, personnel, marketing and call centers, that is HUGE.

BCAN Stock Price could be greatly impacted by this news

# 2 Talking Point

Also BCAN plans include the construction of 4 state of the art greenhouses, housing approximately 2.5 acres of total growing area.

BYND Cannasoft Enterprises Inc. estimates that once fully operational, its Cannabis farm facility will be able to produce 7,500kg of raw cannabis each year.

And right now it has 4 potential catalysts that could provide a massive potential gain in the short term. Here we go:

Check out this float, 878K in THE FLOAT , BCAN has one of the lowest float I have ever seen.

When good or bad news hits a stock that has limited supply, it doesn’t take much for it to leave an impression on the market.

BCAN Stock Price could skyrocket because it is A low float stock.

This news could be revolutionary for women’s health.

Pay Close Attention.

BYND Cannasoft Enterprises Inc. Signs Agreement for the Acquisition of Israeli-Based Zigi Carmel Initiatives & Investments Ltd. In a Share Swap Agreement Valued at US $28Mn

VANCOUVER, British Columbia, Sept. 18, 2022 (GLOBE NEWSWIRE) — BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) (“BYND” or the “Company”) announced today that it has signed a share purchase agreement to acquire 100% ownership of Zigi Carmel Initiatives & Investments Ltd. (“ZC”) which holds the patent pending intellectual property for a therapeutic device (the “EZ-G device”) that uses low concentrations of CB oils, such as hemp seed oil and other natural oils, to treat certain women’s health issues…

The EZ-G device is a unique, patent-pending device that, combined with proprietary software, regulates the flow of low-concentration CBD oils into the soft tissues of the female reproductive system.

BCAN Stock Price could have a significant PPS increase due to this news.

BYND Cannasoft Enterprises Inc. Launches Beta Test for Managing Farms CRM Platform at Israel’s Weizmann Institute of Science

VANCOUVER, British Columbia, Sept. 28, 2022 (GLOBE NEWSWIRE) — BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) (“BYND” or the “Company”) announced that its subsidiary BYND – Beyond Solutions Ltd. has signed an agreement with the Weizmann Institute of Science for the use of its proprietary software. 

Under the terms of the agreement, the Weizmann Institute of Science will use a beta version of the software provided as SAAS.

So, the beta version will include BYND Cannasoft Enterprises’ C.R.M. System – Job Management (BENEFIT).

Also is a module system (CANNASOFT) for managing farms and greenhouses with varied crops.

Therefore, BYND Cannasoft Enterprises will grant the Weizmann Institute a permit to use the license free of charge for a period of one year, after which the institute will have the right to extend the agreement and the Company will be paid a rate according to the agreement.

Yftah Ben Yaackov, CEO and a Director of BYND, said, “This is an extremely important step in the development of BYND Cannasoft Enterprises medical cann-a-bis software since the Weizmann Institute has many greenhouses of various types that can cover all the development possibilities of the software in the coming year…“

BCAN Stock Price is looking like it could be impacted by this news.

Israel’s Ministry of Health, through the Medical Cannabis Unit, granted BYND Cannasoft Enterprises Inc.’s Subsidiary, Cannasoft an Initial Approval to Engage in Medical Cann-a-bis Without Direct Contact with the Substance

Oct. 18, 2022

Received initial approval to engage in medical cannabis without direct contact.

The approval was with Medical Cannabis Unit at the Ministry of Health of the State of Israel. 

So, Cannasoft received this initial approval as part of the process to obtain a full license.

This allows trading in medical cannabis products through an agreement with a licensed cannabis grower in Israel. 

Cannasoft is in the final stage of obtaining the full license.

DISCLAIMER

Small Cap Exclusive is owned and operated by JBN PARTNERS LLC.

JBN is a US based corporation has been compensated $10,000 from Life Water Media for profiling BCAN. We own ZERO shares in BCAN.

We are paid advertisers, also known as stock touts or stock promoters, who disseminate favorable information (this “Article”) about publicly traded companies (the “Profiled Issuers”).

FULL DISCLAIMER

read more

Splash Beverage ( SBEV ) Signs Blockbuster Deal With TARGET Nationwide!

Sep 20, 2022

SBEV

UPDATE: 9/20/22 @ 2:30 PM ET

Splash Beverage (NYSE:SBEV) is trending up after building a solid base above $2.05

SBEV is now testing resistance & if she breaks through $2.10 we could see mid $2s by end of week.

REMEMBER, this stock has a 52 week high of $5.60 & Yahoo Finances short term rating to Buy RATING.

That is EF Hutton, Investing.Com & Yahoo Finance issuing a BUY rating!

I repeat, That is EF Hutton, Investing.Com & Yahoo Finance issuing a BUY rating!

Original Post: 9/20/22 @ 9:08 AM ET

I wrote a report a few days ago on the fact that SALT Tequila, the emerging tequila brand owned by Splash Beverages, could be the next Casa Amigos.

Then, this morning, SPLASH the parent company announces a authorization agreement with Target nationwide!

It is becoming very clear to me that Splash Beverage is not trying to be the next Casa Amigos but the next Coca Cola!

Splash Beverage has made two major announcements over the last few weeks:

  1. Tapout their sports line gets picked up by Targets nationwide!
  2. Salt Tequila signs a national distribution agreement with the same distributors that represent Coca Cola & Anheuser Busch!

Let’s take a closer look at the THREE reasons why SBEV is poised to be a leader in the beverage industry.

splash beverage

I can’t stress this enough, this is HUGE news! 

Respected Technical Analysis site Investing.com issued a Bullish Strong BUY Rating, which could be potentially signaling a bigger breakout to the upside is coming. See technicals below.

splash beverage

ANOTHER BUY RECOMMENDATION

Equity Analyst EF Hutton Initiated a “BUY” Recommendation and Staggering $5.00/Share Price Target!

Additionally, Global Investment Bank Equity Analyst EF Hutton initiated coverage on Splash Beverage Group (NYSE: SBEV) issuing a “BUY” Recommendation and a staggering $5.00/share price target!

splash beverage

*Representing an approx. 133%+ in upside potential from current price

Splash Beverage

Splash announced a Blockbuster Distribution announcement Last Week that SALT Tequila continues its Aggressive National Expansion with full distribution agreements throughout the states of Nevada and Maryland.

Splash Beverage Group’s SALT Tequila Continues Expansion with Full Coverage in Nevada and Maryland

Fort Lauderdale, Florida, Sept. 13, 2022 (GLOBE NEWSWIRE) — Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), a portfolio company of leading beverage brands, announced that SALT Tequila continues its national expansion with full distribution agreements throughout the states of Nevada and Maryland.

Splash announced that Central Distributors of Las Vegas will now distribute SALT Tequila across Nevada. At the same time, the Company announced agreements with Maryland-based Carey Distributors and Wantz Distributors to round out statewide distribution with along with Buck Distributing (previously announced) to distribute SALT throughout Maryland.

Robert Nistico, Splash Beverage Group’s Chairman and CEO, commented, “We’re honored to partner with these top tier distribution companies as consumer demand for SALT Tequila continues to grow along with the entire tequila segment nationally.  We believe SALT is positioned very well to capitalize on this demand; flavored spirits, 100% agave tequilas and the overall tequila segment are key drivers in the spirits segment in the U.S.  The agreement with Central Distributors of Las Vegas provides us with terrific opportunity in the Las Vegas and Reno markets. ‘Vegas-born’ Central Distributors is a family-owned wholesaler distributing a diverse portfolio of premium beverages and we’re proud to have SALT added to their stable.   Similarly, our agreements with Carey Distributors, Wantz Distributors, along with Buck Distributing gives us coverage in the entire state of Maryland with distributors carrying top-tier brands, including Anheuser-Busch and Miller Coors.”

By The Way, SALT has a 5/5 Tasting REVIEW, look out Casa Amigos

Splash Beverage

Fort Lauderdale, Florida, Sept. 20, 2022 (GLOBE NEWSWIRE) — Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), a portfolio company of leading beverage brands, today announced it has received authorization to sell its TapouT performance drink in select Target stores across the nation.

Robert Nistico, Splash Beverage Group’s Chairman and CEO commented, “Target is an iconic premium retailer and one of the most visible retail brands in the nation with stores in all 50 states and the District of Columbia.  75% of the population in the U.S. lives within 10 miles of Target stores and we will now have an opportunity to offer TapouT to these customers.   This is a very exciting new relationship and we’re grateful and proud to have earned this authorization from such important retailer.”

Nistico added, “We continue to execute and put product on retail shelves … and of course product on shelves equals more revenue as we continue to build all our brands coast to coast.”

In closing, SBEV has several potential bullish catalysts in play right now that could catapult them to a household name like Coca Cola.

Splash Beverage is possibly on the verge of Disrupting the $1.86 Trillion Beverage Market.

Just The Tequila Market is a MULTI-BILLION a year industry!

The global tequila market is expected to grow from $10.43 billion in 2022 to $15.57 billion by 2029, at a CAGR of 5.89% in forecast period, 2022-2029

Read More at:-https://www.fortunebusinessinsights.com/tequila-market-104172

Splash Beverage
Tapout,Target,

read more

Splash Beverage ( SBEV ) Signs a GROUNDBREAKING DISTRIBUTION AGREEMENT

Sep 18, 2022

I mention the fact that SALT Tequila, the emerging tequila brand owned by Splash Beverages, could be the next Casa Amigos because of the THREE reasons mentioned above.

Why is Casa Amigos important? Well, it was founded in 2013 and sold for a cool BILLION DOLLARS 4 short years later, in 2017! Read Article HERE

Imagine what would happen to the parent company if this $2 stock had a subsidiary sell for $1 Billion?!?!

Below you will find these 3 reasons that establish, arguably, a better start to this emerging tequila brand than Casa Amigos!

I can’t stress this enough, this is HUGE news! 

Respected Technical Analysis site Investing.com issued a Bullish Strong BUY Rating, which could be potentially signaling a bigger breakout to the upside is coming. See technicals below.

ANOTHER BUY RECOMMENDATION

Equity Analyst EF Hutton Initiated a “BUY” Recommendation and Staggering $5.00/Share Price Target!

Additionally, Global Investment Bank Equity Analyst EF Hutton initiated coverage on Splash Beverage Group (NYSE: SBEV) issuing a “BUY” Recommendation and a staggering $5.00/share price target!

*Representing an approx. 133%+ in upside potential from current price

Splash announced a Blockbuster Distribution announcement Last Week that SALT Tequila continues its Aggressive National Expansion with full distribution agreements throughout the states of Nevada and Maryland.

Splash Beverage Group’s SALT Tequila Continues Expansion with Full Coverage in Nevada and Maryland

Fort Lauderdale, Florida, Sept. 13, 2022 (GLOBE NEWSWIRE) — Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), a portfolio company of leading beverage brands, announced that SALT Tequila continues its national expansion with full distribution agreements throughout the states of Nevada and Maryland.

Splash announced that Central Distributors of Las Vegas will now distribute SALT Tequila across Nevada. At the same time, the Company announced agreements with Maryland-based Carey Distributors and Wantz Distributors to round out statewide distribution with along with Buck Distributing (previously announced) to distribute SALT throughout Maryland.

Robert Nistico, Splash Beverage Group’s Chairman and CEO, commented, “We’re honored to partner with these top tier distribution companies as consumer demand for SALT Tequila continues to grow along with the entire tequila segment nationally.  We believe SALT is positioned very well to capitalize on this demand; flavored spirits, 100% agave tequilas and the overall tequila segment are key drivers in the spirits segment in the U.S.  The agreement with Central Distributors of Las Vegas provides us with terrific opportunity in the Las Vegas and Reno markets. ‘Vegas-born’ Central Distributors is a family-owned wholesaler distributing a diverse portfolio of premium beverages and we’re proud to have SALT added to their stable.   Similarly, our agreements with Carey Distributors, Wantz Distributors, along with Buck Distributing gives us coverage in the entire state of Maryland with distributors carrying top-tier brands, including Anheuser-Busch and Miller Coors.”

By The Way, SALT has a 5/5 Tasting REVIEW, look out Casa Amigos

In closing, SBEV has several potential bullish catalysts in play right now that could catapult them to a household name like Casa Amigos.

Splash Beverage is possibly on the verge of Disrupting the $1.86 Trillion Beverage Market.

Just The Tequila Market is a MULTI-BILLION a year industry!

The global tequila market is expected to grow from $10.43 billion in 2022 to $15.57 billion by 2029, at a CAGR of 5.89% in forecast period, 2022-2029

Read More at:-https://www.fortunebusinessinsights.com/tequila-market-104172

read more

CXKJ Stock Price is up over 44%, is it over? Exclusive Report

Jul 6, 2022

CX Network Group CXKJ stock price is up 44 YTD & volume is up 22%, but can this breakout stock go even higher?

There is an old adage, “two heads are better than one”, so let’s collaborate on CXKJ and compare notes.

In this in depth report, I look at 5 KPIs: Technical Analysis, Volume, News Cycle, Fundamentals & awareness campaigns. I believe the stock market is not gambling, it is also not fool proof, but I have developed a dependable system. I have found some critical components to success for CXKJ, tell me what you think.

Before we get started, I like being methodical and easy to understand so I have developed a ranking system for my stocks. I call it, Alexander Goldman’s “HOT Stock Ranking!”

CA:XBC stock price

The official heat level for CXKJ is, a 🔥🔥 2 out of 4

Before I get ahead of myself and just jump right into this exciting breakout stock, I wanted to introduce myself.

Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading small cap stocks, breakout stocks and trending stocks for 20 years now. I’m accredited for establishing the coveted HOT Stock Reporting system for breakout stocks.

To find out more about my story, CLICK HERE


[thrive_leads id=’28419′]

CX Network Group Company Information

Company Name: CX Network Group Inc.

Ticker: CXKJ

Exchange: OTC

Website: https://www.cxnetwork.com/

CX Network Group Company Summary:

CX Network Group, Inc. focuses on development and operation of online dating and mobile gaming products. Its online dating products are Little Love and Hotchat. The company mobile applications helps users to search and communicate with other like-minded individuals. CX Network Group was founded by Edward Sanders on September 3, 2010 and is headquartered in Dongguan, China.

CXKJ stock price is due to News?

No relevant news

CXKJ

CXKJ Stock Price HOT Stock Grade:

The official heat level for CXKJ is, a 🔥🔥 2 out of 4 . Here are my takeaways on it and why it is just a 3 out of 4. Do you agree?

CXKJ Trading Volume

The volume, is trading at an increase of 25% over the average which indicates a higher demand in the stock.

Trading 101: volume is measured in the number of shares traded. Traders look to volume to determine liquidity and combine changes in volume with technical indicators to make trading decisions. So, let’s take a look at the technical indicators.

CXKJ Technicals

The technical analysis “chart reading”, it is bullish and has been that way since the early part of this month with a steady ascending channel. It is bullish but what goes up must come down! Be careful

Trading 101: Technical indicators are technical tools that help in analyzing the movement in the stock prices whether the ongoing trend is going to continue or reverse. It helps the traders to make entry and exit decisions of a particular stock. Technical indicators can be leading or lagging indicators.

CXKJ News Cycle

The news, there is no significant news.

CXKJ Fundamentals

The fundamentals, there is exciting financial filings associated with this stock, “265% growth”!

CXKJ

Trading 101: Fundamental trading is a method where a trader focuses on company-specific events to determine which stock to buy and when to buy it. Trading on fundamentals is more closely associated with a buy-and-hold strategy rather than short-term trading.

CXKJ Awareness

Marketing efforts “Awareness Campaigns”, I have not found marketing efforts around the investor awareness of this company. Hence the 3 out of 4. Do you agree? Write me a line at [email protected]

Again, two heads are better than one, let’s work together to have the best trading year of our lives!

To receive my 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

To find out more about my story, CLICK HERE

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥 HOT stocks and we can compare notes!👇


[thrive_leads id=’28419′]

read more

OMER Stock Price could be ready for a run? URGENT

Jul 6, 2022

Omeros OMER stock price is finally showing some life as it reverses trend.

OMER is up 35% in the last 5 days and I will be evaluating many factors to determine just how hot the stock is.

The official heat level for SMCE is, a 🔥🔥 2 out of 5.

Continue reading to see why I think it is just a 2 out of 5. There is some shocking takeaways from this article that you must read if you are interested in OMER.

If you are interested in finding out more about me, famed stock picker, Alexander Goldman or if you’re interested in my HOT grading system, sign up today, it’s FREE!

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥🔥 HOT stocks and trending stocks!👇 In fact, I will send you personally a 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter.


[thrive_leads id=’14274′]

Before I go over this exciting trending stock, I wanted to introduce myself. Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading, at a very high level, breakout stocks and trending stocks for 20 years now. I’m accredited for establishing the coveted HOT grading system for trending stocks.

I found my home at Small Cap exclusive 4 years ago. Now, I’m helping traders find breakout stocks. Not to sound egotistical but I’m very good at finding small cap stocks that are winners.

What do I mean by big winners?

Stocks that move more than 100% in a month! OMER Stock Price could?

Does that always happen, NO! But, I’m very consistent! Take a look at this article I wrote below, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!

The article is HERE and I shine a spotlight on these breakout stocks and also those losers!

Now, let’s go over some of the basic information on this stock before we get in the technical analysis and how I came up with HOT grade.

Omeros Company Information

Company Name: Omeros Inc.

Ticker: OMER

Exchange: NASDAQ

Website: https://www.omeros.com/

Breakout Stock Omeros Company Summary:

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

OMER stock price is due to News?

NONE

OMER

OMER Stock Price HOT Stock Grade:

The official heat level for OMER is, a 🔥🔥 2 out of 5 . Continue reading to see why I think it is just a 2 out of 5. Here are my takeaways on OMER and why it is just a 2 out of 5.

The volume, which is basically demand of a stock is sporadic and has a downward pressure on it.

The news, there is no significant news cycle circulating around OMER stock price.

The chart, I love it, it looks bullish and it has been that way for over a month!

The fundamentals, there is no exciting financial filings associated with this stock.

Marketing efforts, I have found marketing efforts around the investor awareness of this company which saved it from a 1 out of 5 rating.

To receive my 🔥🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥🔥 HOT stocks and trending stocks!👇


[thrive_leads id=’14274′]

read more